|
COPS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.036800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.436900E-03 |
| Normal-vs-Stage2 |
6.707700E-02 |
| Normal-vs-Stage3 |
4.206200E-04 |
| Normal-vs-Stage4 |
1.121810E-02 |
| Stage1-vs-Stage2 |
9.071400E-01 |
| Stage1-vs-Stage3 |
1.173360E-01 |
| Stage1-vs-Stage4 |
6.822600E-01 |
| Stage2-vs-Stage3 |
2.510200E-01 |
| Stage2-vs-Stage4 |
6.800800E-01 |
| Stage3-vs-Stage4 |
4.412400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.848300E-04 |
| Normal-vs-AfricanAmerican |
6.303000E-01 |
| Normal-vs-Asian |
1.340240E-02 |
| Caucasian-vs-AfricanAmerican |
7.828000E-02 |
| Caucasian-vs-Asian |
9.701200E-01 |
| AfricanAmerican-vs-Asian |
1.272220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.032400E-02 |
| Normal-vs-Female |
1.575600E-03 |
| Male-vs-Female |
3.510800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.015900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.657820E-03 |
| Normal-vs-Age(61-80Yrs) |
6.979900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.264000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.811400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.533800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.939200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.941800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.198600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.044600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.438800E-01 |
| Classical-VS-Follicular |
8.582400E-01 |
| Classical-VS-Other |
2.898800E-01 |
| Classical-VS-Normal |
5.421500E-03 |
| Tall-VS-Follicular |
4.671200E-01 |
| Tall-VS-Other |
1.541360E-01 |
| Tall-VS-Normal |
1.249600E-02 |
| Follicular-VS-Other |
3.813400E-01 |
| Follicular-VS-Normal |
3.383500E-02 |
| Other-VS-Normal |
9.228200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.200700E-03 |
| Normal-vs-N1 |
3.135600E-03 |
| N0-vs-N1 |
5.102000E-01 |
|
|
